Fri, 15 Jun 2018 06:05:26 GMT
Australian drugmaker Sirtex sees getting approval for China's buyout
Sirtex, Australia's liver cancer treatment manufacturer, is expecting its $1.4B buyout by China's consortium to win the regulatory approval in the United States and Australia, despite some diplomatic tensions.